In vivo protection by broadly neutralizing HIV antibodies.

Trends Microbiol

Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, The Netherlands; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA. Electronic address:

Published: October 2014

Passive immunization studies, including a recent one by Pegu et al., have repeatedly shown that HIV-specific broadly neutralizing antibodies (bnAbs) protect rhesus macaques from HIV acquisition. In vitro neutralization potency and in vivo protection correlate very strongly, supporting the quest for an HIV vaccine that induces potent bnAbs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tim.2014.08.006DOI Listing

Publication Analysis

Top Keywords

vivo protection
8
broadly neutralizing
8
protection broadly
4
neutralizing hiv
4
hiv antibodies
4
antibodies passive
4
passive immunization
4
immunization studies
4
studies including
4
including pegu
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!